Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Non Operating Interest Expenses (2018 - 2020)

Acadia Pharmaceuticals (ACAD) posted Non Operating Interest Expenses of $1.5 million for Q1 2020, up 12375.0% on a QoQ basis from $12000.0 in Q2 2019, and up 553.71% year-over-year from $229000.0 in Q2 2019.

Analysis

Acadia Pharmaceuticals (ACAD) Non Operating Interest Expenses (2018 - 2020) Analysis & Trends

Acadia Pharmaceuticals has reported Non Operating Interest Expenses for 3 years, with the latest figure at $1.5 million in Q1 2020.

  • On a quarterly basis, Non Operating Interest Expenses rose 553.71% year-over-year to $1.5 million in Q1 2020; TTM through Mar 2020 was $1.6 million, a 22.14% decrease from a year earlier, with the FY2018 full-year figure at $1.8 million, changed N/A from the prior year.
  • Non Operating Interest Expenses was $1.5 million for Q1 2020 at Acadia Pharmaceuticals, up from $12000.0 in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $1.7 million in Q3 2018, with the low at -$127000.0 in Q4 2018.
  • Average Non Operating Interest Expenses over 3 years is $596333.3, with a median of $238000.0 recorded in 2018.
  • The sharpest annual moves came in 2019 and 2020: Non Operating Interest Expenses plunged 95.14% in 2019, then jumped 553.71% in 2020.
  • Over 3 years, Non Operating Interest Expenses stood at -$127000.0 in 2018, then soared by 109.45% to $12000.0 in 2019, then jumped by 12375.0% to $1.5 million in 2020.
  • The last three Non Operating Interest Expenses figures came in at $1.5 million (Q1 2020), $12000.0 (Q2 2019), and $229000.0 (Q1 2019), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 281.00 Mn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -435.00 Mn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 247.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 1.50 Mn
Jun 30, 2019 12,000.00
Mar 31, 2019 229,000.00
Dec 31, 2018 -127,000.00
Sep 30, 2018 1.72 Mn
Jun 30, 2018 247,000.00
API Access

Acadia Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ACAD&period=max&api_key=YOUR_API_KEY